Abstract
Francisella tularensis is a facultative intracellular bacterium that infects many cell types, including neutrophils. We demonstrated previously that F. tularensis inhibits NADPH oxidase assembly and activity and then escapes the phagosome to the cytosol, but effects on other aspects of neutrophil function are unknown. Neutrophils are short-lived cells that undergo constitutive apoptosis, and phagocytosis typically accelerates this process. We now demonstrate that F. tularensis significantly inhibited neutrophil apoptosis as indicated by morphologic analysis as well as annexin V and TUNEL staining. Thus, ∼80% of infected neutrophils remained viable at 48 h compared with ∼50% of control cells, and ∼40% of neutrophils that ingested opsonized zymosan. In keeping with this finding, processing and activation of procaspases-8, -9, and -3 were markedly diminished and delayed. F. tularensis also significantly impaired apoptosis triggered by Fas crosslinking. Of note, these effects were dose dependent and could be conferred by either intracellular or extracellular live bacteria, but not by formalin-killed organisms or isolated LPS and capsule, and were not affected by disruption of wbtA2 or FTT1236/FTL0708—genes required for LPS O-antigen and capsule biosynthesis. In summary, we demonstrate that F. tularensis profoundly impairs constitutive neutrophil apoptosis via effects on the intrinsic and extrinsic pathways, and thereby define a new aspect of innate immune evasion by this organism. As defects in neutrophil turnover prevent resolution of inflammation, our findings also suggest a mechanism that may in part account for the neutrophil accumulation, granuloma formation, and severe tissue damage that characterizes lethal pneumonic tularemia.
Footnotes
J.T.S. designed and performed experiments, interpreted data, and cowrote the manuscript. J.H.B. designed and performed experiments, interpreted data, and edited the manuscript. J.K., D.C.F., and J.M.M. designed and performed experiments and interpreted data. L.-A.H.A. conceived the study, obtained financial support, designed experiments, interpreted data, and cowrote the manuscript.
This work was supported by National Institutes of Health Grants R01AI073835 and P01AI044642 (to L.-A.H.A.) and T32AI007511 (predoctoral fellowship to J.T.S.).
The online version of this article contains supplemental material.
Abbreviations used in this article:
- BSL
- biosafety level
- CHAB
- cysteine heart agar supplemented with 9% defibrinated sheep blood
- fk
- formalin-killed
- hpi
- hours postinfection
- LDH
- lactate dehydrogenase
- LVS
- live vaccine strain
- MOI
- multiplicity of infection
- OpZ
- opsonized zymosan
- PI
- propidium iodide
- PMN
- polymorphonuclear leukocyte
- PS
- phosphatidylserine
- ROS
- reactive oxygen species.
- Received October 4, 2011.
- Accepted January 23, 2012.
- Copyright © 2012 by The American Association of Immunologists, Inc.